Calendar Frazier Lifesciences Acquisition Corporation

Equities

NAMS

NL00150012L7

Real-time Estimate Tradegate 02:16:57 2024-05-15 pm EDT 5-day change 1st Jan Change
18.15 EUR -10.19% Intraday chart for Frazier Lifesciences Acquisition Corporation -8.96% +80.93%

Chart calendar Frazier Lifesciences Acquisition Corporation

b113c1a.ppg8E2QqlPZosWCf9VnC4RQeK1ncZ6wWftr2pfHj7hU.k9REWA9pxJAe3C_-vz2rs2YrGD-6PfZQGZDC5pChliz-wndZLkz2gUXiFw~ceb640935749c54168ec599a3277d38e

Upcoming events on Frazier Lifesciences Acquisition Corporation

2024-05-16 09:00 am R&D Day - Key Opinion Leader
2024-06-05 06:00 pm Annual General Meeting
2024-08-04 Q2 2024 Earnings Release (Projected)
2024-11-10 Q3 2024 Earnings Release (Projected)
2025-03-27 Q4 2024 Earnings Release (Projected)
2025-05-06 Q1 2025 Earnings Release (Projected)

Past events on Frazier Lifesciences Acquisition Corporation

2024-05-14 04:35 pm RBC Capital Markets Global Healthcare Conference
2024-05-09 08:00 am Q1 2024 Earnings Release
2024-04-07 01:15 pm American College of Cardiology Scientific Meeting
2024-03-11 Jefferies Biotech on the Bay Summit
2024-03-11 04:00 pm Leerink Partners Global Biopharma Conference
2024-03-04 02:10 pm TD Cowen Health Care Conference
2024-02-28 08:00 am Q4 2023 Earnings Release
2024-02-07 01:00 pm Guggenheim Healthcare Talks Biotechnology Conference
2023-11-28 03:30 pm Piper Sandler Healthcare Conference
2023-11-16 05:30 am Jefferies London Healthcare Conference
2023-11-13 08:00 am Q3 2023 Earnings Release
2023-09-27 01:50 pm Cantor Global Healthcare Conference
2023-08-07 07:15 am Q2 2023 Earnings Release
2023-06-07 03:30 pm Jefferies Global Healthcare Conference
2023-06-05 08:00 am Obicetrapib Phase 2b Clinical Trial Results Call
2023-06-03 12:00 pm National Lipid Association Scientific Meeting
2023-05-08 08:00 am Q1 2023 Earnings Release
2023-03-31 08:00 am Q4 2022 Earnings Release
2023-03-08 02:50 pm Cowen Health Care Conference
2023-02-16 01:00 pm SVB Securities Global Biopharma Conference

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024
Net sales
Million EUR
Released
Forecast
Spread
0,00


97,5
98,2
-0.69%
13,0
14,2
-8.63%

10,6

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million EUR
Released
Forecast
Spread
0,00


-6,96
7,11
-197.91%
-169
-172
2.01%

-182

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
0,00


-78,1
7,00
-1215.03%
-163
-169
3.52%

-202

Net income
Million EUR
Released
Forecast
Spread
-28,6


-78,1
7,00
-1215.03%
-163
-167
2.45%

-206

EPS
EUR
Released
Forecast
Spread
-2,53


-0,96
0,08
-1300%
-1,98
-2,03
2.24%

-2,30

Announcement Date04/08/2231/03/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million EUR
Released
Forecast
Spread

3,50


1,75

4,00
7,20
-44.44%

1,47


1,95

9,56



1,77

1,30
1,61
-18.88%

1,27


2,11


4,76


0,00


0,00

EBITDA
Million EUR
Released
Forecast
Spread










27,6


29,0

























EBIT
Million EUR
Released
Forecast
Spread

-25,5


-25,8





-34,2


-36,7





-48,0

-51,6
-47,4
-9.01%

-49,5


-44,3


-37,0


-36,4


-31,6

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread




-39,3





-33,7


-37,5





-48,2

-93,8
-36,2
-158.85%

-46,2


-39,9


-34,6


-31,7


-26,8

Net income
Million EUR
Released
Forecast
Spread




-39,2





-33,7


-36,1

-75,1



-46,9

-93,8
-43,6
-115.03%

-47,3


-40,6


-35,6


-31,7


-26,8

EPS
EUR
Released
Forecast
Spread




-0,45





-0,41


-0,43

-0,92



-0,56

-0,99
-0,49
-101.98%

-0,53


-0,45


-0,39


-0,35


-0,30

Announcement Date--31/03/23--07/08/23-08/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NAMS Stock
  4. Calendar Frazier Lifesciences Acquisition Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW